Hospital supply chain leaders are rethinking how reliability, cost control and clinical alignment can coexist as traditional strategies fall short. A Feb. 24 report from ECRI argues that amid rising pressure, decisions must be built on structured, decision-ready evidence—not instinct or preference.
The report builds on themes echoed by supply chain leaders, where executives cited growing concern over sourcing instability, internal variation and pressure to justify supply chain investments. “The biggest challenge right now is the collision between macroeconomic volatility and internal clinical variation,” said Michael Alfaro, materials director at Community Memorial Healthcare in California.
ECRI warns that many decisions unravel not because they’re wrong, but because they can’t withstand scrutiny after implementation. Without clear evaluation criteria, clinical input, and documented risk trade-offs, teams face delays, disputes and compliance gaps.
To address this, the report recommends integrating evidence earlier in the decision process, aligning teams on evaluation standards, and distinguishing between acceptable clinical variation and avoidable inconsistency.
ECRI said systems that prioritize decision integrity are more likely to reduce rework, preserve clinical trust and maintain operational discipline in a volatile supply landscape.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
